InfuSystem Holdings Approves Equity Plan Amendment, New Chairman

The latest update is out from InfuSystem Holdings ( (INFU) ).

At the 2025 Annual Meeting of Stockholders held on May 15, 2025, InfuSystem Holdings, Inc. announced the approval of the Second Amendment to its 2021 Equity Incentive Plan, increasing the maximum number of shares reserved for issuance to 6,000,000. This amendment, along with other approved proposals, aims to enhance the company’s operational flexibility and governance structure. Additionally, Ronald Hundzinski was elected as the Chairman of the Board of Directors, reflecting a shift in leadership dynamics. The meeting also saw the approval of several amendments to the company’s Certificate of Incorporation, including changes to forum selection for stockholder actions and officer exculpation, as well as the ratification of Deloitte & Touche LLP as the independent accounting firm for 2025.

The most recent analyst rating on (INFU) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.

Spark’s Take on INFU Stock

According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.

InfuSystem Holdings demonstrates solid financial performance and a positive earnings outlook, driven by strong revenue growth and cash flow management. However, the mixed technical signals and high P/E ratio suggest caution. While the company is well-positioned for growth, potential overvaluation and high short-term momentum indicators slightly moderate the overall score.

To see Spark’s full report on INFU stock, click here.

More about InfuSystem Holdings

InfuSystem Holdings, Inc. operates in the healthcare industry, providing infusion pumps and related products and services. The company focuses on offering solutions for healthcare providers and patients, enhancing the delivery of care through its equipment and services.

Average Trading Volume: 145,004

Technical Sentiment Signal: Sell

Current Market Cap: $128.4M

Find detailed analytics on INFU stock on TipRanks’ Stock Analysis page.